Third Wave Technologies is a company dedicated to developing and marketing molecular diagnostic products for DNA and RNA analysis. With a focus on precision disease analysis and treatment, the company utilizes its proprietary Invader chemistry technology in segments such as women's health, infectious diseases, genetics, and pharmacogenetics, as well as oncology. Its offerings include inVitro diagnostic devices and analyte-specific reagents, enabling laboratories to develop assays for various diseases and genetic mutations. Additionally, the company caters to the research and agricultural biotechnology markets with its range of DNA and RNA analysis products.
Founded in 1993 and based in Madison, Wisconsin, Third Wave Technologies was acquired by Hologic Inc. in 2008. The company's customer base includes clinical laboratories, pharmaceutical and biotechnology firms, academic research centers, and healthcare providers, with a distribution network that spans the U.S. and Europe. The latest venture round investment in Third Wave Technologies was led by SV Health Investors on March 23, 2011.
Overall, Third Wave Technologies stands as a pioneering force in molecular innovations, particularly in women's health, oncology, and infectious diseases, supplying crucial molecular solutions to the medical and research communities alike.
